RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Botanix Pharmaceuticals Stock

Botanix Pharmaceuticals ROCE 2024

Botanix Pharmaceuticals ROCE

-0.11

Ticker

BOT.AX

ISIN

AU000000BOT2

WKN

A2ANJ5

In 2024, Botanix Pharmaceuticals's return on capital employed (ROCE) was -0.11, a -93.11% increase from the -1.61 ROCE in the previous year.

Botanix Pharmaceuticals Aktienanalyse

What does Botanix Pharmaceuticals do?

Botanix Pharmaceuticals Ltd is an Australian company specializing in the research and development of innovative therapies based on synthetic cannabinoids. The company was founded in 2014 by a team of experts and is headquartered in Perth, Western Australia. The history of Botanix Pharmaceuticals began with the discovery of the medical properties of cannabinoids derived from the hemp plant. Cannabinoids have a wide therapeutic potential, ranging from pain and inflammation relief to the treatment of seizure disorders and anxiety. Botanix Pharmaceuticals utilizes these properties to develop innovative product candidates that have high efficacy and tolerability. The business model of Botanix Pharmaceuticals is based on the concept of targeted treatment for diseases and conditions where traditional therapies are insufficient or cause unwanted side effects. The company develops and produces medications based on synthetic cannabinoids that target specific disease states and indications. Botanix Pharmaceuticals specializes in two areas. Firstly, it focuses on the development of topical products, such as ointments and creams, that are applied to the skin. These products are particularly effective in treating skin conditions such as acne or psoriasis. Secondly, the company is working on the development of medications for the treatment of internal conditions such as epilepsy or chronic obstructive pulmonary disease (COPD). In the field of topical products, Botanix Pharmaceuticals has already achieved significant success. The company has a promising pipeline of product candidates for various applications, including acne, psoriasis, atopic dermatitis, and bacterial infections. One promising drug candidate is BTX 1503, which was developed for the treatment of severe acne. It contains the synthetic cannabinoid BTX 1308, which possesses anti-inflammatory and antimicrobial properties. BTX 1503 has already demonstrated high efficacy and tolerability in clinical studies. In the field of internal conditions, Botanix Pharmaceuticals collaborates closely with leading institutions and research facilities to develop innovative therapies for seizure disorders and COPD. One promising product candidate is BTX 1801, which was developed for the treatment of severe epilepsy. BTX 1801 contains the synthetic cannabinoid BTX 1204, which has shown high efficacy and tolerability in the treatment of seizures. Botanix Pharmaceuticals is an innovative company that develops highly effective and tolerable medications based on synthetic cannabinoids. The company has already achieved remarkable success in a short period and has established itself as a leading player in the industry. With its pipeline of promising product candidates and its close collaboration with renowned research institutions, Botanix Pharmaceuticals is well-positioned to develop further innovative therapies in the future. Botanix Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Botanix Pharmaceuticals's Return on Capital Employed (ROCE)

Botanix Pharmaceuticals's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Botanix Pharmaceuticals's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Botanix Pharmaceuticals's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Botanix Pharmaceuticals’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Botanix Pharmaceuticals stock

What is the ROCE (Return on Capital Employed) of Botanix Pharmaceuticals this year?

The ROCE of Botanix Pharmaceuticals is -0.11 undefined this year.

How has the ROCE (Return on Capital Employed) of Botanix Pharmaceuticals developed compared to the previous year?

The ROCE of Botanix Pharmaceuticals has increased by -93.11% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Botanix Pharmaceuticals?

A high Return on Capital Employed (ROCE) indicates that Botanix Pharmaceuticals has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Botanix Pharmaceuticals?

A low ROCE (Return on Capital Employed) can indicate that Botanix Pharmaceuticals has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Botanix Pharmaceuticals impact the company?

An increase in the ROCE of Botanix Pharmaceuticals can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Botanix Pharmaceuticals affect the company?

A decrease in ROCE of Botanix Pharmaceuticals can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Botanix Pharmaceuticals?

Some factors that can affect Botanix Pharmaceuticals's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Botanix Pharmaceuticals so important for investors?

The ROCE of Botanix Pharmaceuticals is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Botanix Pharmaceuticals take to improve the ROCE?

To improve the ROCE, Botanix Pharmaceuticals can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Botanix Pharmaceuticals pay?

Over the past 12 months, Botanix Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Botanix Pharmaceuticals is expected to pay a dividend of 0 AUD.

What is the dividend yield of Botanix Pharmaceuticals?

The current dividend yield of Botanix Pharmaceuticals is .

When does Botanix Pharmaceuticals pay dividends?

Botanix Pharmaceuticals pays a quarterly dividend. This is distributed in the months of April, October, April, November.

How secure is the dividend of Botanix Pharmaceuticals?

Botanix Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Botanix Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Botanix Pharmaceuticals located?

Botanix Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Botanix Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Botanix Pharmaceuticals from 10/25/1996 amounting to 0.048 AUD, you needed to have the stock in your portfolio before the ex-date on 10/3/1996.

When did Botanix Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/25/1996.

What was the dividend of Botanix Pharmaceuticals in the year 2023?

In the year 2023, Botanix Pharmaceuticals distributed 0 AUD as dividends.

In which currency does Botanix Pharmaceuticals pay out the dividend?

The dividends of Botanix Pharmaceuticals are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Botanix Pharmaceuticals

Our stock analysis for Botanix Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Botanix Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.